Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Satomi Nagashima"'
Autor:
Shinichiroh Yokota, Shunsuke Doi, Masakazu Fukuhara, Tomohiro Mitani, Satomi Nagashima, Wataru Gonoi, Takeshi Imai, Kazuhiko Ohe
Publikováno v:
Health and Technology. 13:65-73
Publikováno v:
Drug Metabolism and Pharmacokinetics. 23:54-58
We reported the human flavin-containing monooxygenase 3 (FMO3) haplotypes (Pharmacogenet. Genomics: 17, 827, 2007). The objective was to gain the insight into transcriptional regulation in a Japanese population. The wild-type FMO3 reporter plasmids c
Publikováno v:
Drug metabolism and pharmacokinetics. 30(1)
Human flavin-containing monooxygenase 3 (FMO3) in the liver catalyzes a variety of oxygenations of nitrogen- and sulfur-containing medicines and xenobiotic substances. Because of growing interest in drug interactions mediated by polymorphic FMO3, ben
Autor:
John R. Cashman, Hiroshi Yano, Satomi Nagashima, Hiroshi Yamazaki, Jun Zhang, Norie Murayama, Makiko Shimizu
Publikováno v:
Drug Metabolism and Disposition. 35:328-330
The decreased capacity of the flavin-containing monooxygenase 3 (FMO3) to oxygenate xenobiotics including trimethylamine is believed to contribute to metabolic disorders. The aim of this study was to functionally characterize FMO3 variants recently f
Autor:
Hiroshi Yano, Shinichi Kobayashi, Norie Murayama, Toshio Kumai, Satomi Nagashima, F. Peter Guengerich, Makiko Shimizu, Hiroshi Yamazaki
Publikováno v:
Drug metabolism and pharmacokinetics. 24(3)
Human flavin-containing monooxygenase 3 (FMO3)-mediated microsomal oxygenation activities, levels of FMO3 protein and FMO3 mRNA, and its modification were investigated in Japanese livers genotyped for the FMO3 gene. Significant correlations were obse